CANNT Journal - Effectiveness of furosemide in patients on peritoneal dialysis
July 1, 2006 -- Abstract Background Residual renal function (RRF) is a marker for a good index of health and is associated with improved survival for individuals...
Southern Medical Journal - Sweet syndrome associated with furosemide.(Case Report)
May 1, 2005 -- Abstract: This case report describes a case of Sweet syndrome (SS) related to use of furosemide in a 46-year-old female who was admitted for...
Journal of Drugs in Dermatology - Furosemide-induced bullous pemphigoid: case report and review of literature
June 1, 2006 -- Abstract Bullous pemphigoid (BP) is an acquired autoimmune disease characterized by subepidermal vesicles and bullae. The etiology for BP is mostly...
Journal of Family Practice - Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?
April 1, 2005 -- * Evidence-Based Answer No large-scale randomized, placebo-controlled trials evaluate furosemide's effect on mortality and long-term morbidity in...
Clinical Chemistry - The Fludrocortisone/Furosemide test - a safe, effective and well tolerated urine acidification test
June 1, 2006 -- A-65 A. Viljoen, A. G. Norden, F. E. Karet. Addenbrookes Hospital, Cambridge, United Kingdom, The ammonium chloride (NM^sub 4^Cl) urine acidification...
Journal of Nuclear Medicine Technology - Selected Cases Demonstrating the Value of Furosemide-Primed ^sup 18^F-FDG PET in Identifying Adrenal Involvement
September 1, 2005 -- The adrenals are often a site of metastatic spread of cancer, and evaluation of the adrenals is important in assessing the extent of disease...
Journal of AOAC International - A simple and rapid high-performance liquid chromatography method for determining furosemide, hydrochlorothiazide, and phenol red: applicability to intestinal...
January 1, 2006 -- A simple reversed-phase high-performance liquid chromatography (HPLC) method with ultraviolet detection at 280 nm was developed for simultaneous...
Business Wire - Depomed Announces Extended Phase II Results for Furosemide GR in Congestive Heart Failure Patients
May 13, 2005 -- MENLO PARK, Calif. -- Depomed, Inc. (Nasdaq:DEPO) today announced results from its extended Phase II trial of Furosemide GR(TM), a controlled release...
Business Wire - Depomed Initiates Phase II Trial With Once Daily Diuretic Furosemide GR
January 6, 2004 -- Business Editors/Health/Medical Writers BIOWIRE2K MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 6, 2004 Study Will Use invivodata eDiary to Capture...
Business Wire - Depomed Announces Phase II Results for Furosemide GR in Congestive Heart Failure Patients
September 23, 2004 -- MENLO PARK, Calif. -- Depomed, Inc. (Nasdaq:DEPO) today announced preliminary results from its Phase II trial of Furosemide GR, a controlled release...
